The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made ...
Investing.com-- Buyout firm GTCR is close to acquiring generic drugmaker Zentiva in a deal valued at about $4.8 billion, Bloomberg reported on Thursday, citing people familiar with the matter. Chicago ...
PARIS: The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday (Sep 5), calling for cheap generic ...
One of the world’s most sought-after drugs has officially become a vital medication. The World Health Organization has just added semaglutide—the active ingredient in Ozempic and Wegovy—to its list of ...
NEW YORK, Sept 2 (Reuters) - Some Chinese companies now racing to make generic versions of Novo Nordisk's (NOVOb.CO), opens new tab Wegovy also supplied ingredients for more than a billion makeshift ...
Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...
Health Canada is taking longer to assess generic drug applications, lengthening the wait until the cheaper pharmaceuticals can come to market, new data show. The federal regulator’s delays mean that ...
A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of affordable generics. While formulations and APIs are currently excluded, the ...
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will release its second-quarter 2025 financial results tomorrow, July 30. According to Benzinga Pro, the company expects to report second-quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback